Upper gastrointestinal acute graft--host disease adds minimal prognostic value in isolation or with other graft--host disease symptoms as currently diagnosed and treated

about

Upper gastrointestinal acute graft--host disease adds minimal prognostic value in isolation or with other graft--host disease symptoms as currently diagnosed and treated

Item

http://www.wikidata.org/entity/Q58793795

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@en

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@nl

type

Item

label

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@en

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@nl

prefLabel

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@en

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@nl

P1476

Upper gastrointestinal acute g ...... urrently diagnosed and treated

@en

P2093

Amin Alousi

http://www.w3.org/2001/XMLSchema#string

Baldeep Wirk

http://www.w3.org/2001/XMLSchema#string

Corey Cutler

http://www.w3.org/2001/XMLSchema#string

Daniel Couriel

http://www.w3.org/2001/XMLSchema#string

Daniel Weisdorf

http://www.w3.org/2001/XMLSchema#string

David I Marks

http://www.w3.org/2001/XMLSchema#string

Donna Przepiorka

http://www.w3.org/2001/XMLSchema#string

Görgün Akpek

http://www.w3.org/2001/XMLSchema#string

Hanna J Khoury

http://www.w3.org/2001/XMLSchema#string

Hideki Nakasone

http://www.w3.org/2001/XMLSchema#string

P2860

Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation

Defining the intensity of conditioning regimens: working definitions

Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry.

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.

P304

1708-1719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2017.182550

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Sophie Paczesny

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30076185

http://www.w3.org/2001/XMLSchema#string

P921

hematology

P932

6165812

http://www.w3.org/2001/XMLSchema#string